Association Between Elevated Thyroid Peroxidase Antibody and Abdominal Fat Distribution in Patients with Type 2 Diabetes Mellitus

References

• Bray GA, Heisel WE, Afshin A, et al. The science of obesity management: an endocrine society scientific statement. Endocr Rev. 2018;39(2):79–132. doi:10.1210/er.2017-00253
   PubMed Web of Science ®Google Scholar
• Fang L, Guo F, Zhou L, Stahl R, Grams J. The cell size and distribution of adipocytes from subcutaneous and visceral fat is associated with type 2 diabetes mellitus in humans. Adipocyte. 2015;4(4):273–279. doi:10.1080/21623945.2015.1034920
   PubMed Web of Science ®Google Scholar
• González N, Moreno-Villegas Z, González-Bris A, Egido J, Lorenzo Ó. Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes. Cardiovasc Diabetol. 2017;16(1):44. doi:10.1186/s12933-017-0528-4
   PubMed Web of Science ®Google Scholar
• Huang JW, Yang CY, Wu HY, Liu KL, Hung KY. Metabolic syndrome and abdominal fat are associated with inflammation, but not with clinical outcomes, in peritoneal dialysis patients. Cardiovasc Diabetol. 2013;12(1):86. doi:10.1186/1475-2840-12-86
   Web of Science ®Google Scholar
• Ruiz HH, Díez RL, Arivazahagan L, Ramasamy R, Schmidt AM. Metabolism, obesity, and diabetes mellitus. Arterioscler Thromb Vasc Biol. 2019;39(7):e166–e174. doi:10.1161/ATVBAHA.119.312005
   Web of Science ®Google Scholar
• Chistiakov DA. Immunogenetics of Hashimoto’s thyroiditis. J Autoimmune Dis. 2005;2(1):1–21. doi:10.1186/1740-2557-2-1
   PubMedGoogle Scholar
• García-Solís P, García OP, Hernández-Puga G, et al. Thyroid hormones and obesity: a known but poorly understood relationship. Endokrynol Pol. 2018;69(3):292–303. doi:10.5603/EP.2018.0032
   PubMed Web of Science ®Google Scholar
• Chang YC, Hua SC, Chang C-H. High TSH level within normal range is associated with obesity, dyslipidemia, hypertension, inflammation, hypercoagulability, and the metabolic syndrome: a novel cardiometabolic marker. J Clin Med. 2019;8(6):817. doi:10.3390/jcm8060817
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen Y, Wang N, et al. Thyroid stimulating hormone within the reference range is associated with visceral adiposity index and lipid accumulation product: a population-based study of SPECT-China. Horm Metab Res. 2018;50(1):29–36. doi:10.1055/s-0043-122235
   Web of Science ®Google Scholar
• Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12(4):287–293. doi:10.1089/10507250252949405
   PubMed Web of Science ®Google Scholar
• Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol. 2005;62(4):487–491. doi:10.1111/j.1365-2265.2005.02247.x
   PubMed Web of Science ®Google Scholar
• Kitahara CM, Platz EA, Ladenson PW, Mondul AM, Menke A, Berrington de González A. Body fatness and markers of thyroid function among U.S. men and women. PLoS One. 2012;7(4):e34979. doi:10.1371/journal.pone.0034979
   PubMed Web of Science ®Google Scholar
• Asvold BO, Vatten LJ, Nilsen TI, Bjøro T. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol. 2007;156(2):181–186. doi:10.1530/eje.1.02333
   PubMed Web of Science ®Google Scholar
• De Pergola G, Ciampolillo A, Paolotti S, Trerotoli P, Giorgino R. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol. 2007;67(2):265–269. doi:10.1111/j.1365-2265.2007.02874.x
   PubMed Web of Science ®Google Scholar
• Pearce EN. Thyroid hormone and obesity. Curr Opin Endocrinol Diabetes Obes. 2012;19(5):408–413. doi:10.1097/MED.0b013e328355cd6c
   PubMedGoogle Scholar
• Ren R, Jiang X, Zhang X, et al. Association between thyroid hormones and body fat in euthyroid subjects. Clin Endocrinol. 2014;80(4):585–590. doi:10.1111/cen.12311
   PubMed Web of Science ®Google Scholar
• Roef GL, Rietzschel ER, Van Daele CM, et al. Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects. Thyroid. 2014;24(2):223–231. doi:10.1089/thy.2013.0314
   PubMed Web of Science ®Google Scholar
• Tamer G, Mert M, Tamer I, Mesci B, Kilic D, Arik S. Effects of thyroid autoimmunity on abdominal obesity and hyperlipidaemia. Endokrynol Pol. 2011;62(5):421–428.
   PubMed Web of Science ®Google Scholar
• Dosi RV, Tandon N. A study on prevalence of thyroid auto-immunity in type 1 diabetes mellitus. J Indian Med Assoc. 2010;108(6):349–350, 355–346.
   Google Scholar
• Shun CB, Donaghue KC, Phelan H, Twigg SM, Craig ME. Thyroid autoimmunity in Type 1 diabetes: systematic review and meta-analysis. Diabet Med. 2014;31(2):126–135. doi:10.1111/dme.12318
   PubMed Web of Science ®Google Scholar
• Elebrashy IN, El Meligi A, Rashed L, Salam RF, Youssef E, Fathy SA. Thyroid dysfunction among type 2 diabetic female Egyptian subjects. Ther Clin Risk Manag. 2016;12:1757–1762.
   PubMed Web of Science ®Google Scholar
• Sarfo-Kantanka O, Sarfo FS, Ansah EO, et al. Frequency and determinants of thyroid autoimmunity in Ghanaian type 2 diabetes patients: a case-control study. BMC Endocr Disord. 2017;17(1):2. doi:10.1186/s12902-016-0152-4
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang N, Chen Y, et al. The association of non-alcoholic fatty liver disease with thyroid peroxidase and thyroglobulin antibody: a new insight from SPECT-China study. Autoimmunity. 2018;51(5):238–244. doi:10.1080/08916934.2018.1488968
   PubMed Web of Science ®Google Scholar
• Wang C, Niu Q, Lv H. Elevated TPOAb is a strong predictor of autoimmune development in patients of type 2 diabetes mellitus and non-alcoholic fatty liver disease: a case-control study. Diabetes Metab Syndr Obes. 2020;13:4369–4378. doi:10.2147/DMSO.S280231
   PubMed Web of Science ®Google Scholar
• Sotak S, Felsoci M, Lazurova I. Type 2 diabetes mellitus and thyroid disease: a two-sided analysis. Bratisl Lek Listy. 2018;119(6):361–365. doi:10.4149/BLL_2018_067
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 4. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S37–S47. doi:10.2337/dc20-S004
   PubMed Web of Science ®Google Scholar
• Song RH, Wang B, Yao QM, Li Q, Jia X, Zhang JA. The impact of obesity on thyroid autoimmunity and dysfunction: a systematic review and meta-analysis. Front Immunol. 2019;10:2349. doi:10.3389/fimmu.2019.02349
   PubMed Web of Science ®Google Scholar
• Fleiner HF, Bjøro T, Midthjell K, Grill V, Åsvold BO. Prevalence of thyroid dysfunction in autoimmune and type 2 diabetes: the population-based HUNT study in Norway. J Clin Endocrinol Metab. 2016;101(2):669–677. doi:10.1210/jc.2015-3235
   PubMed Web of Science ®Google Scholar
• Mousa U, Bozkuş Y, Kut A, Demir CC, Tutuncu NB. Fat distribution and metabolic profile in subjects with Hashimoto’s thyroiditis. Acta Endocrinol. 2018;14(1):105–112. doi:10.4183/aeb.2018.105
   Google Scholar
• Lu S, Guan Q, Liu Y, et al. Role of extrathyroidal TSHR expression in adipocyte differentiation and its association with obesity. Lipids Health Dis. 2012;11:17. doi:10.1186/1476-511X-11-17
   PubMed Web of Science ®Google Scholar
• Fröhlich E, Wahl R. Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases. Front Immunol. 2017;8:521. doi:10.3389/fimmu.2017.00521
   PubMed Web of Science ®Google Scholar
• Ruggeri RM, Vicchio TM, Cristani M, et al. Oxidative stress and advanced glycation end products in Hashimoto’s thyroiditis. Thyroid. 2016;26(4):504–511. doi:10.1089/thy.2015.0592
   PubMed Web of Science ®Google Scholar
• Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr. 1985;41(4):810–817. doi:10.1093/ajcn/41.4.810
   PubMed Web of Science ®Google Scholar
• Park KS, Lee DH, Lee J, et al. Comparison between two methods of bioelectrical impedance analyses for accuracy in measuring abdominal visceral fat area. J Diabetes Complications. 2016;30(2):343–349. doi:10.1016/j.jdiacomp.2015.10.014
   PubMed Web of Science ®Google Scholar
• Yuji M. New criteria for “obesity disease” in Japan: the examination committee of criteria for ‘obesity disease’in Japan, Japan society for the study of obesity. New criteria for ‘obesity disease’in Japan. Circ J. 2002;66(11):987–992. doi:10.1253/circj.66.987
   Web of Science ®Google Scholar